Source: Drug Development Research. Unidades: IFSC, FMRP
Subjects: FÁRMACOS (ESTUDO;DESENVOLVIMENTO), DOENÇAS PARASITÁRIAS (ESTUDO;TRATAMENTO), MALÁRIA (TRATAMENTO), PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS
ABNT
GARCIA, Mariana Lopes et al. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors. Drug Development Research, v. 83, n. 2, p. 264-284, 2022Tradução . . Disponível em: https://doi.org/10.1002/ddr.21646. Acesso em: 14 ago. 2024.APA
Garcia, M. L., Oliveira, A. A. de, Bueno, R. V., Nogueira, V. H. R., Souza, G. E., & Guido, R. V. C. (2022). QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors. Drug Development Research, 83( 2), 264-284. doi:10.1002/ddr.21646NLM
Garcia ML, Oliveira AA de, Bueno RV, Nogueira VHR, Souza GE, Guido RVC. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors [Internet]. Drug Development Research. 2022 ; 83( 2): 264-284.[citado 2024 ago. 14 ] Available from: https://doi.org/10.1002/ddr.21646Vancouver
Garcia ML, Oliveira AA de, Bueno RV, Nogueira VHR, Souza GE, Guido RVC. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors [Internet]. Drug Development Research. 2022 ; 83( 2): 264-284.[citado 2024 ago. 14 ] Available from: https://doi.org/10.1002/ddr.21646